Scientists at the University of Massachusetts Amherst have developed the first artificial neuron capable of directly “communicating” with living cells — all without the need for any external signal amplification devices.
The U.S. Food and Drug Administration (FDA) has announced the most serious type of market recall (Class I) for Impella heart pump controllers manufactured by a company owned by Johnson & Johnson, citing discovered cybersecurity flaws.
The U.S. Senate has passed an amendment to the defense budget bill banning federal funding for projects involving Chinese biotechnology companies deemed a threat to national security.
OpenAI and Broadcom have entered into a partnership that will result in the first dedicated AI chips in OpenAI’s history. The company aims to reduce its reliance on external chip manufacturers — and the market response has been overwhelmingly positive.